Market Insight – Courts' rulings spell confusion for brand names
This article was originally published in Scrip
Executive Summary
The branding of pharmaceuticals including, increasingly, branded generics is of huge importance to pharma companies. Vast amounts of time and money are spent in clearing new names for novel drugs (and also in clearing non-proprietary names) and protecting them through the trademark registration system in the hope that everything will be in place by the time the product is ready to launch.